Literature DB >> 11097847

Overexpression of vacuolar ATPase 16-kDa subunit in 10T1/2 fibroblasts enhances invasion with concomitant induction of matrix metalloproteinase-2.

S Kubota1, Y Seyama.   

Abstract

Recent studies show that the vacuolar-type H(+)-ATPase (V-ATPase) 16 kDa subunit is expressed on plasma membrane of cancer cells. We hypothesized that V-ATPase 16 kDa subunit is directly involved in cell invasion. In the present study we established transfectants overexpressing V-ATPase 16 kDa subunit at the mRNA level, and found that these transfectants showed an enhanced invasiveness through matrigel with a concomitant increases in secretion of matrix metalloproteinase-2. Moreover, antisense oligonucleotides of the V-ATPase 16 kDa subunit suppressed invasive human A549 cell invasion with concomitant decreases in secretion of matrix metalloproteinase-2. The results suggest that the V-ATPase 16 kDa subunit is directly involved in cell invasion and that matrix metalloproteinase-2 is responsible for promoting the invasion by the V-ATPase 16 kDa subunit. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097847     DOI: 10.1006/bbrc.2000.3802

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.

Authors:  Ayana Hinton; Souad R Sennoune; Sarah Bond; Min Fang; Moshe Reuveni; G Gary Sahagian; Daniel Jay; Raul Martinez-Zaguilan; Michael Forgac
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

2.  Inhibitors of vacuolar ATPase proton pumps inhibit human prostate cancer cell invasion and prostate-specific antigen expression and secretion.

Authors:  Vera Michel; Yamhilette Licon-Munoz; Kristina Trujillo; Marco Bisoffi; Karlett J Parra
Journal:  Int J Cancer       Date:  2012-09-21       Impact factor: 7.396

Review 3.  The curious case of vacuolar ATPase: regulation of signaling pathways.

Authors:  Sahithi Pamarthy; Arpita Kulshrestha; Gajendra K Katara; Kenneth D Beaman
Journal:  Mol Cancer       Date:  2018-02-15       Impact factor: 27.401

4.  F-actin reorganization by V-ATPase inhibition in prostate cancer.

Authors:  Yamhilette Licon-Munoz; Vera Michel; Colleen A Fordyce; Karlett J Parra
Journal:  Biol Open       Date:  2017-11-15       Impact factor: 2.422

5.  V-ATPase-dependent repression of androgen receptor in prostate cancer cells.

Authors:  Yamhilette Licon-Munoz; Colleen A Fordyce; Summer Raines Hayek; Karlett J Parra
Journal:  Oncotarget       Date:  2018-06-22

6.  ATP6L promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition.

Authors:  Jingyi Wang; Dandan Chen; Wangzhao Song; Zhiyong Liu; Wenjuan Ma; Xiaofeng Li; Chao Zhang; Xin Wang; Yalei Wang; Ye Yang; Wenfeng Cao; Lisha Qi
Journal:  Cancer Sci       Date:  2020-01-06       Impact factor: 6.716

7.  Vacuolar H+-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling.

Authors:  Sung Wook Son; Gia Cac Chau; Seong-Tae Kim; Sung Hee Um
Journal:  Cells       Date:  2019-09-24       Impact factor: 6.600

8.  Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays.

Authors:  Jie Yao; Zhan Zhang; Sheng Li; Bai Li; Xing-Huan Wang
Journal:  J Cell Mol Med       Date:  2019-11-05       Impact factor: 5.295

9.  An independent endocytic pathway stimulates different monocyte subsets by the a2 N-terminus domain of vacuolar-ATPase.

Authors:  Christina Kwong; Alice Gilman-Sachs; Kenneth Beaman
Journal:  Oncoimmunology       Date:  2013-01-01       Impact factor: 8.110

10.  Effects of Vacuolar H+-ATPase Inhibition on Activation of Cathepsin B and Cathepsin L Secreted from MDA-MB231 Breast Cancer Cells.

Authors:  Andrew Uhlman; Kelly Folkers; Jared Liston; Harshida Pancholi; Ayana Hinton
Journal:  Cancer Microenviron       Date:  2017-08-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.